BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Boeckxstaens G, El-Serag HB, Smout AJ, Kahrilas PJ. Symptomatic reflux disease: the present, the past and the future. Gut. 2014;63:1185-1193. [PMID: 24607936 DOI: 10.1136/gutjnl-2013-306393] [Cited by in Crossref: 143] [Cited by in F6Publishing: 102] [Article Influence: 17.9] [Reference Citation Analysis]
Number Citing Articles
1 de Vegt F, Gommers JJJ, Groenewoud H, Siersema PD, Verbeek ALM, Peters Y, Broeders MJM. Trends and projections in the incidence of oesophageal cancer in the Netherlands: An age-period-cohort analysis from 1989 to 2041. Int J Cancer 2022;150:420-30. [PMID: 34605022 DOI: 10.1002/ijc.33836] [Reference Citation Analysis]
2 Koch OO, Antoniou SA. Advances in diagnosing GERD: Which examinations should be performed before interventional therapy? Eur Surg 2016;48:203-8. [DOI: 10.1007/s10353-016-0435-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
3 Brar TS, Draganov PV, Yang D. Endoluminal Therapy for Gastroesophageal Reflux Disease: In Between the Pill and the Knife? Dig Dis Sci 2017;62:16-25. [DOI: 10.1007/s10620-016-4355-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
4 Bang CS, Yang YJ, Baik GH. Melatonin for the treatment of gastroesophageal reflux disease; protocol for a systematic review and meta-analysis. Medicine (Baltimore). 2019;98:e14241. [PMID: 30681611 DOI: 10.1097/md.0000000000014241] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
5 Chung H, Chon YE, Kim SU, Lee SK, Jung KS, Han KH, Chon CY. Noninvasive Prediction of Erosive Esophagitis Using a Controlled Attenuation Parameter (CAP)-Based Risk Estimation Model. Dig Dis Sci 2016;61:507-16. [PMID: 26441279 DOI: 10.1007/s10620-015-3902-7] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
6 Lee H, Lim Y, Chi S, Min YW, Min BH, Lee JH, Rhee PL, Kim JJ. Relationship between obesity and development of erosive reflux disease: A mediation analysis of the role of cardiometabolic risk factors. Sci Rep 2017;7:6375. [PMID: 28743962 DOI: 10.1038/s41598-017-06845-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
7 Kim TJ, Lee H, Baek SY, Kim K, Min YW, Min BH, Lee JH, Son HJ, Rhee PL, Kim JJ. Metabolically Healthy Obesity and the Risk of Erosive Esophagitis: A Cohort Study. Clin Transl Gastroenterol 2019;10:e00077. [PMID: 31498243 DOI: 10.14309/ctg.0000000000000077] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Ishimura N, Owada Y, Aimi M, Oshima T, Kamada T, Inoue K, Mikami H, Takeuchi T, Miwa H, Higuchi K, Kinoshita Y. No increase in gastric acid secretion in healthy Japanese over the past two decades. J Gastroenterol 2015;50:844-52. [DOI: 10.1007/s00535-014-1027-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
9 Pan J, Cen L, Chen W, Yu C, Li Y, Shen Z. Alcohol Consumption and the Risk of Gastroesophageal Reflux Disease: A Systematic Review and Meta-analysis. Alcohol Alcohol 2019;54:62-9. [PMID: 30184159 DOI: 10.1093/alcalc/agy063] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
10 Person E, Rife C, Freeman J, Clark A, Castell DO. A Novel Sleep Positioning Device Reduces Gastroesophageal Reflux: A Randomized Controlled Trial. Journal of Clinical Gastroenterology 2015;49:655-9. [DOI: 10.1097/mcg.0000000000000359] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
11 Khodamoradi Z, Gandomkar A, Poustchi H, Salehi A, Imanieh MH, Etemadi A, Malekzadeh R. Prevalence and Correlates of Gastroesophageal Reflux Disease in Southern Iran: Pars Cohort Study. Middle East J Dig Dis 2017;9:129-38. [PMID: 28894514 DOI: 10.15171/mejdd.2017.63] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
12 Hu HQ, Li HK, Xiong Y, Zhang XB, Zhi JL, Wang XX, Ling-Hu EQ. Peroral endoscopic cardial constriction in gastroesophageal reflux disease.Medicine (Baltimore). 2018;97:e0169. [PMID: 29642142 DOI: 10.1097/MD.0000000000010169] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
13 Thereaux J, Lesuffleur T, Czernichow S, Basdevant A, Msika S, Nocca D, Millat B, Fagot-Campagna A. Do sleeve gastrectomy and gastric bypass influence treatment with proton pump inhibitors 4 years after surgery? A nationwide cohort. Surg Obes Relat Dis 2017;13:951-9. [PMID: 28223087 DOI: 10.1016/j.soard.2016.12.013] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
14 Min YW, Shin I, Son HJ, Rhee PL. Multiple Rapid Swallow Maneuver Enhances the Clinical Utility of High-Resolution Manometry in Patients Showing Ineffective Esophageal Motility. Medicine (Baltimore) 2015;94:e1669. [PMID: 26448010 DOI: 10.1097/MD.0000000000001669] [Cited by in Crossref: 21] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
15 Stephan D, Attwood S, Labenz J, Willeke F. EndoStim®-Therapie – eine neue minimal-invasive Technologie in der Antirefluxchirurgie. Chirurg 2018;89:785-92. [DOI: 10.1007/s00104-018-0706-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
16 Miron I, Dumitrascu DL. GASTROINTESTINAL MOTILITY DISORDERS IN OBESITY. Acta Endocrinol (Buchar) 2019;15:497-504. [PMID: 32377248 DOI: 10.4183/aeb.2019.497] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Kahrilas PJ, Keefer L, Pandolfino JE. Patients with refractory reflux symptoms: What do they have and how should they be managed? Neurogastroenterol Motil. 2015;27:1195-1201. [PMID: 26303047 DOI: 10.1111/nmo.12644] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
18 Kim GH. It Is Time to Meet the Challenges of the Changing Epidemiology of Gastroesophageal Reflux Disease. J Neurogastroenterol Motil 2018;24:507-9. [PMID: 30347932 DOI: 10.5056/jnm18152] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Ghisa M, Marinelli C, Savarino V, Savarino E. Idiopathic pulmonary fibrosis and GERD: links and risks. Ther Clin Risk Manag 2019;15:1081-93. [PMID: 31564886 DOI: 10.2147/TCRM.S184291] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
20 Kim SY, Park B, Lim H, Kim M, Kong IG, Choi HG. Gastroesophageal reflux disease increases the risk of chronic rhinosinusitis: a nested case-control study using a national sample cohort. Int Forum Allergy Rhinol 2019;9:357-62. [PMID: 30548214 DOI: 10.1002/alr.22259] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
21 Qian J, Li Y, Yao H, Tian H, Wang H, Ai L, Xie Y, Bao Y, Liang L, Hu Y, Zhang Y, Wang J, Li C, Tang J, Chen Y, Xu J, Fang JY. ASAP3 regulates microvilli structure in parietal cells and presents intervention target for gastric acidity. Signal Transduct Target Ther 2017;2:17003. [PMID: 29263912 DOI: 10.1038/sigtrans.2017.3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
22 Launois C, Mulette P, Ancel J, Dury S, Hagenburg J, Lebargy F, Dormoy V, Deslee G, Perotin JM. [Treatment of GERD in asthma]. Rev Mal Respir 2021:S0761-8425(21)00234-5. [PMID: 34016495 DOI: 10.1016/j.rmr.2021.04.013] [Reference Citation Analysis]
23 Bonfiglio F, Hysi PG, Ek W, Karhunen V, Rivera NV, Männikkö M, Nordenstedt H, Zucchelli M, Bresso F, Williams F, Tornblom H, Magnusson PK, Pedersen NL, Ronkainen J, Schmidt PT, D'Amato M. A meta-analysis of reflux genome-wide association studies in 6750 Northern Europeans from the general population. Neurogastroenterol Motil 2017;29. [PMID: 27485664 DOI: 10.1111/nmo.12923] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
24 Tolone S, De Bortoli N, Marabotto E, de Cassan C, Bodini G, Roman S, Furnari M, Savarino V, Docimo L, Savarino E. Esophagogastric junction contractility for clinical assessment in patients with GERD: a real added value? Neurogastroenterol Motil. 2015;27:1423-1431. [PMID: 26227513 DOI: 10.1111/nmo.12638] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 8.1] [Reference Citation Analysis]
25 Spechler SJ. Evaluation and Treatment of Patients with Persistent Reflux Symptoms Despite Proton Pump Inhibitor Treatment. Gastroenterol Clin North Am 2020;49:437-50. [PMID: 32718563 DOI: 10.1016/j.gtc.2020.04.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
26 Benedix F, Adolf D, Peglow S, Gstettenbauer LM, Croner R. Short-term outcome after robot-assisted hiatal hernia and anti-reflux surgery-is there a benefit for the patient? Langenbecks Arch Surg 2021;406:1387-95. [PMID: 33409583 DOI: 10.1007/s00423-020-02051-2] [Reference Citation Analysis]
27 Bai P, Bano S, Kumar S, Sachdev P, Ali A, Dembra P, Bachani P, Shahid S, Jamil A, Rizwan A. Gastroesophageal Reflux Disease in the Young Population and Its Correlation With Anxiety and Depression. Cureus 2021;13:e15289. [PMID: 34194886 DOI: 10.7759/cureus.15289] [Reference Citation Analysis]
28 Xiao Y, Liang M, Peng S, Zhang N, Chen M. Tailored therapy for the refractory GERD patients by combined multichannel intraluminal impedance-pH monitoring: Tailor therapy of refractory GERD. Journal of Gastroenterology and Hepatology 2016;31:350-4. [DOI: 10.1111/jgh.13049] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
29 Hunter JG, Kahrilas PJ, Bell RC, Wilson EB, Trad KS, Dolan JP, Perry KA, Oelschlager BK, Soper NJ, Snyder BE, Burch MA, Melvin WS, Reavis KM, Turgeon DG, Hungness ES, Diggs BS. Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial. Gastroenterology. 2015;148:324-333.e5. [PMID: 25448925 DOI: 10.1053/j.gastro.2014.10.009] [Cited by in Crossref: 102] [Cited by in F6Publishing: 72] [Article Influence: 12.8] [Reference Citation Analysis]
30 Zhao A, Wang MC, Szeto IMY, Meng LP, Wang Y, Li T, Zhang YM. Gastrointestinal discomforts and dietary intake in Chinese urban elders: A cross-sectional study in eight cities of China. World J Gastroenterol 2019; 25(45): 6681-6692 [PMID: 31832006 DOI: 10.3748/wjg.v25.i45.6681] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
31 Kahrilas P, Yadlapati R, Roman S. Emerging dilemmas in the diagnosis and management of gastroesophageal reflux disease. F1000Res 2017;6:1748. [PMID: 29034088 DOI: 10.12688/f1000research.11918.1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
32 Liu L, Li S, Zhu K, Yu W, Wang H, Guo J, Gao H. Relationship between esophageal motility and severity of gastroesophageal reflux disease according to the Los Angeles classification. Medicine (Baltimore) 2019;98:e15543. [PMID: 31083209 DOI: 10.1097/MD.0000000000015543] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
33 Labenz J, Labenz G, Stephan D, Willeke F; LOPA-Studiengruppe. [Insufficient symptom control under long-term treatment with PPI in GERD - fact or fiction? MMW Fortschr Med. 2016;158 Suppl 4:7-11. [PMID: 27221555 DOI: 10.1007/s15006-016-8303-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
34 Kim JJ, Kim N, Park JH, Kim YS, Lee SM, Lee DH, Jung HC. Comparison of Tight Junction Protein-Related Gene mRNA Expression Levels between Male and Female Gastroesophageal Reflux Disease Patients. Gut Liver 2018;12:411-9. [PMID: 29558791 DOI: 10.5009/gnl17419] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
35 Shaheen NJ, Falk GW, Iyer PG, Gerson LB; American College of Gastroenterology. ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus. Am J Gastroenterol. 2016;111:30-50; quiz 51. [PMID: 26526079 DOI: 10.1038/ajg.2015.322] [Cited by in Crossref: 793] [Cited by in F6Publishing: 630] [Article Influence: 113.3] [Reference Citation Analysis]
36 Rettura F, Bronzini F, Campigotto M, Lambiase C, Pancetti A, Berti G, Marchi S, de Bortoli N, Zerbib F, Savarino E, Bellini M. Refractory Gastroesophageal Reflux Disease: A Management Update. Front Med (Lausanne) 2021;8:765061. [PMID: 34790683 DOI: 10.3389/fmed.2021.765061] [Reference Citation Analysis]
37 Kandulski A, Moleda L, Müller-Schilling M. Diagnostic Investigations of Gastroesophageal Reflux Disease: Who and When to Refer and for What Test? Visc Med 2018;34:97-100. [PMID: 29888237 DOI: 10.1159/000488184] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Yadlapati R, Pandolfino JE, Greytak M, Cahoon J, Clarke M, Clary M, Fink D, Menard-Katcher P, Vahabzadeh-Hagh AM, Weissbrod P, Gupta S, Kaizer A, Wani S. Upper Esophageal Sphincter Compression Device as an Adjunct to Proton Pump Inhibition for Laryngopharyngeal Reflux. Dig Dis Sci 2021. [PMID: 34275061 DOI: 10.1007/s10620-021-07172-2] [Reference Citation Analysis]
39 Disantis DJ. Esophagography and gastroesophageal reflux disease: utilization and utility. Abdom Radiol 2018;43:1306-7. [DOI: 10.1007/s00261-018-1470-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Kim SY, Park B, Lim H, Kim M, Kong IG, Choi HG. Increased risk of larynx cancer in patients with gastroesophageal reflux disease from a national sample cohort. Clin Otolaryngol 2019;44:534-40. [DOI: 10.1111/coa.13328] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
41 Bytzer P, Reimer C, Smith G, Anatchkova MD, Hsieh R, Wilkinson J, Thomas SJ, Lenderking WR. Psychometric evaluation of a daily gastro-oesophageal reflux disease symptom measure. Scandinavian Journal of Gastroenterology 2017;52:276-83. [DOI: 10.1080/00365521.2016.1250282] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
42 Vaezi MF, Pandolfino JE, Vela MF, Shaheen NJ. White Paper AGA: Optimal Strategies to Define and Diagnose Gastroesophageal Reflux Disease. Clinical Gastroenterology and Hepatology 2017;15:1162-72. [DOI: 10.1016/j.cgh.2017.03.021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
43 Leiman DA, Riff BP, Morgan S, Metz DC, Falk GW, French B, Umscheid CA, Lewis JD. Alginate therapy is effective treatment for GERD symptoms: a systematic review and meta-analysis. Dis Esophagus 2017;30:1-9. [PMID: 28375448 DOI: 10.1093/dote/dow020] [Cited by in Crossref: 55] [Cited by in F6Publishing: 35] [Article Influence: 11.0] [Reference Citation Analysis]
44 Coyle C, Crawford G, Wilkinson J, Thomas SJ, Bytzer P. Randomised clinical trial: addition of alginate-antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms. Aliment Pharmacol Ther 2017;45:1524-33. [DOI: 10.1111/apt.14064] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
45 Coronel MA, Bernardo WM, Moura DTHD, Moura ETHD, Ribeiro IB, Moura EGHD. THE EFFICACY OF THE DIFFERENT ENDOSCOPIC TREATMENTS VERSUS SHAM, PHARMACOLOGIC OR SURGICAL METHODS FOR CHRONIC GASTROESOPHAGEAL REFLUX DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS. Arq Gastroenterol 2018;55:296-305. [DOI: 10.1590/s0004-2803.201800000-65] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
46 Savarino E, Zentilin P, Marabotto E, Bodini G, Della Coletta M, Frazzoni M, de Bortoli N, Martinucci I, Tolone S, Pellegatta G, Savarino V. A review of pharmacotherapy for treating gastroesophageal reflux disease (GERD). Expert Opin Pharmacother. 2017;18:1333-1343. [PMID: 28754071 DOI: 10.1080/14656566.2017.1361407] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
47 Liu L, Gao H, Wang H, Yu W, Zhu K, Zhang Y, Guo J. Comparison of Esophageal Function Tests to Investigate the Effect of Helicobacter Pylori Infection on Gastroesophageal Reflux Disease (GERD). Med Sci Monit. 2018;24:4791-4797. [PMID: 29992917 DOI: 10.12659/msm.908051] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
48 Hopkins J, Switzer NJ, Karmali S. Update on novel endoscopic therapies to treat gastroesophageal reflux disease: A review. World J Gastrointest Endosc 2015; 7(11): 1039-1044 [PMID: 26322157 DOI: 10.4253/wjge.v7.i11.1039] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
49 Chen C, Gong X, Yang X, Shang X, Du Q, Liao Q, Xie R, Chen Y, Xu J. The roles of estrogen and estrogen receptors in gastrointestinal disease. Oncol Lett 2019;18:5673-80. [PMID: 31788039 DOI: 10.3892/ol.2019.10983] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
50 Fofaria RK, Morris DL. Hiatus hernia and gastro-oesophageal reflux disease. Medicine 2015;43:192-6. [DOI: 10.1016/j.mpmed.2015.01.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
51 Offman J, Fitzgerald RC. Alternatives to Traditional Per-Oral Endoscopy for Screening. Gastrointest Endosc Clin N Am 2017;27:379-96. [PMID: 28577763 DOI: 10.1016/j.giec.2017.02.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
52 Singhal S, Masuda T, Mittal SK. Do the Data Support Manometric Subclassifications for Ineffective Esophageal Motility? Clin Transl Gastroenterol 2017;8:e95. [PMID: 28569740 DOI: 10.1038/ctg.2017.21] [Reference Citation Analysis]
53 Le Bras GF, Farooq MH, Falk GW, Andl CD. Esophageal cancer: The latest on chemoprevention and state of the art therapies. Pharmacol Res 2016;113:236-44. [PMID: 27565381 DOI: 10.1016/j.phrs.2016.08.021] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
54 Sanghi V, Thota PN. Barrett's esophagus: novel strategies for screening and surveillance. Ther Adv Chronic Dis 2019;10:2040622319837851. [PMID: 30937155 DOI: 10.1177/2040622319837851] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
55 Akiyama J, Kuribayashi S, Baeg MK, Bortoli N, Valitova E, Savarino EV, Kusano M, Triadafilopoulos G. Current and future perspectives in the management of gastroesophageal reflux disease. Ann N Y Acad Sci 2018;1434:70-83. [DOI: 10.1111/nyas.13850] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
56 Patel A, Sayuk GS, Kushnir VM, Chan WW, Gyawali CP. GERD phenotypes from pH-impedance monitoring predict symptomatic outcomes on prospective evaluation. Neurogastroenterol Motil. 2016;28:513-521. [PMID: 26686239 DOI: 10.1111/nmo.12745] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
57 Frye JW, Peura DA. Managing gastroesophageal reflux disease - comparative efficacy and outcomes of dexlansoprazole MR. Ther Clin Risk Manag 2015;11:1649-56. [PMID: 26586949 DOI: 10.2147/TCRM.S66680] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
58 Pleyer C, Bittner H, Locke GR, Choung RS, Zinsmeister AR, Schleck CD, Herrick LM, Talley NJ. Overdiagnosis of gastro-esophageal reflux disease and underdiagnosis of functional dyspepsia in a USA community. Neurogastroenterol Motil. 2014;26:1163-1171. [PMID: 24916517 DOI: 10.1111/nmo.12377] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
59 Leiman DA, Riff BP, Morgan S, Metz DC, Falk GW, French B, Umscheid CA, Lewis JD. Alginate therapy is effective treatment for gastroesophageal reflux disease symptoms: a systematic review and meta-analysis. Dis Esophagus 2017;30:1-8. [PMID: 27671545 DOI: 10.1111/dote.12535] [Cited by in Crossref: 5] [Article Influence: 1.0] [Reference Citation Analysis]
60 Davis TME, Drinkwater J, Davis WA. Proton Pump Inhibitors, Nephropathy, and Cardiovascular Disease in Type 2 Diabetes: The Fremantle Diabetes Study. The Journal of Clinical Endocrinology & Metabolism 2017;102:2985-93. [DOI: 10.1210/jc.2017-00354] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
61 Baeg MK, Ko SH, Ko SY, Jung HS, Choi MG. Obesity increases the risk of erosive esophagitis but metabolic unhealthiness alone does not: a large-scale cross-sectional study. BMC Gastroenterol 2018;18:82. [PMID: 29884133 DOI: 10.1186/s12876-018-0814-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
62 Spechler SJ. Refractory Gastroesophageal Reflux Disease and Functional Heartburn. Gastrointestinal Endoscopy Clinics of North America 2020;30:343-59. [DOI: 10.1016/j.giec.2019.12.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
63 Gyawali CP, Fass R. Management of Gastroesophageal Reflux Disease. Gastroenterology. 2018;154:302-318. [PMID: 28827081 DOI: 10.1053/j.gastro.2017.07.049] [Cited by in Crossref: 109] [Cited by in F6Publishing: 75] [Article Influence: 21.8] [Reference Citation Analysis]
64 Wetselaar P, Manfredini D, Ahlberg J, Johansson A, Aarab G, Papagianni CE, Reyes Sevilla M, Koutris M, Lobbezoo F. Associations between tooth wear and dental sleep disorders: A narrative overview. J Oral Rehabil 2019;46:765-75. [PMID: 31038764 DOI: 10.1111/joor.12807] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
65 Garg SK, Gurusamy KS. Laparoscopic fundoplication surgery versus medical management for gastro-oesophageal reflux disease (GORD) in adults. Cochrane Database Syst Rev 2015;:CD003243. [PMID: 26544951 DOI: 10.1002/14651858.CD003243.pub3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
66 Bor S, Kalkan İH, Çelebi A, Dinçer D, Akyüz F, Dettmar P, Özen H. Alginates: From the ocean to gastroesophageal reflux disease treatment. Turk J Gastroenterol 2019;30:109-36. [PMID: 31624050 DOI: 10.5152/tjg.2019.19677] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
67 Molina-Infante J, van Rhijn BD. Interactions between gastro-oesophageal reflux disease and eosinophilic oesophagitis. Best Pract Res Clin Gastroenterol 2015;29:749-58. [PMID: 26552774 DOI: 10.1016/j.bpg.2015.06.009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
68 Kim JY, Shin IS, Min YW, Kim K, Lee H, Min BH, Lee JH, Kim JJ, Rhee PL. Endoscopic Prediction for Acid Reflux in Patients without Hiatus Hernia. Korean J Gastroenterol 2020;76:134-41. [PMID: 32969361 DOI: 10.4166/kjg.2020.76.3.134] [Reference Citation Analysis]
69 Nishizawa T, Mori K, Yoshida S, Ebinuma H, Toyoshima O, Suzuki H. Additional Mosapride to Proton Pump Inhibitor for Gastroesophageal Reflux Disease: A Meta-Analysis. J Clin Med 2020;9:E2705. [PMID: 32825721 DOI: 10.3390/jcm9092705] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 Burton L, Beattie J, Falk GL, Van der Wall H, Coman W. The burden of gastroesophageal reflux disease on the cost of managing chronic diseases in Australia. The need for a new diagnostic and management paradigm. Chronic Illn 2020;:1742395320966373. [PMID: 33070630 DOI: 10.1177/1742395320966373] [Reference Citation Analysis]
71 Kim SY, Kim HJ, Lim H, Kong IG, Kim M, Choi HG. Bidirectional association between gastroesophageal reflux disease and depression: Two different nested case-control studies using a national sample cohort. Sci Rep 2018;8:11748. [PMID: 30082758 DOI: 10.1038/s41598-018-29629-7] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 10.5] [Reference Citation Analysis]
72 Jamshed S, Bhagavathula AS, Zeeshan Qadar SM, Alauddin U, Shamim S, Hasan S. Cost-effective Analysis of Proton Pump Inhibitors in Long-term Management of Gastroesophageal Reflux Disease: A Narrative Review. Hosp Pharm 2020;55:292-305. [PMID: 32999499 DOI: 10.1177/0018578719893378] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
73 Castelijns PSS, Ponten JEH, Van de Poll MCG, Nienhuijs SW, Smulders JF. Subjective outcome after laparoscopic hiatal hernia repair for intrathoracic stomach. Langenbecks Arch Surg 2017;402:521-30. [PMID: 27830367 DOI: 10.1007/s00423-016-1504-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
74 Ko S, Baeg MK, Jung HS, Kim P, Choi M. Russian Caucasians have a higher risk of erosive reflux disease compared with East Asians: A direct endoscopic comparison. Neurogastroenterol Motil 2017;29:e13002. [DOI: 10.1111/nmo.13002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
75 Kahrilas PJ, Altman KW, Chang AB, Field SK, Harding SM, Lane AP, Lim K, McGarvey L, Smith J, Irwin RS; CHEST Expert Cough Panel. Chronic Cough Due to Gastroesophageal Reflux in Adults: CHEST Guideline and Expert Panel Report. Chest 2016;150:1341-60. [PMID: 27614002 DOI: 10.1016/j.chest.2016.08.1458] [Cited by in Crossref: 77] [Cited by in F6Publishing: 59] [Article Influence: 12.8] [Reference Citation Analysis]
76 Jeong S, Bak J, Kim SM, Kang HW. Feasibility study of endoscopic thermal coagulation with circumferential laser irradiation for treating esophageal tissue. Lasers Med Sci 2020;35:893-900. [PMID: 31641966 DOI: 10.1007/s10103-019-02877-3] [Reference Citation Analysis]
77 Pandit S, Boktor M, Alexander JS, Becker F, Morris J. Gastroesophageal reflux disease: A clinical overview for primary care physicians. Pathophysiology. 2018;25:1-11. [PMID: 28943113 DOI: 10.1016/j.pathophys.2017.09.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
78 Mello MD, Shriver AR, Li Y, Patel A, Gyawali CP. Ineffective esophageal motility phenotypes following fundoplication in gastroesophageal reflux disease. Neurogastroenterol Motil 2016;28:292-8. [PMID: 26575034 DOI: 10.1111/nmo.12728] [Cited by in Crossref: 45] [Cited by in F6Publishing: 33] [Article Influence: 6.4] [Reference Citation Analysis]
79 Azagury DE, Triadafilopoulos G. Minimally Invasive GERD Therapies. In: Vaezi MF, editor. Diagnosis and Treatment of Gastroesophageal Reflux Disease. Cham: Springer International Publishing; 2016. pp. 117-43. [DOI: 10.1007/978-3-319-19524-7_7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
80 Keung C, Hebbard G. The management of gastro-oesophageal reflux disease. Aust Prescr 2016;39:6-10. [PMID: 27041798 DOI: 10.18773/austprescr.2016.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
81 Fock KM, Talley N, Goh KL, Sugano K, Katelaris P, Holtmann G, Pandolfino JE, Sharma P, Ang TL, Hongo M, Wu J, Chen M, Choi MG, Law NM, Sheu BS, Zhang J, Ho KY, Sollano J, Rani AA, Kositchaiwat C, Bhatia S. Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett's oesophagus. Gut. 2016;65:1402-1415. [PMID: 27261337 DOI: 10.1136/gutjnl-2016-311715] [Cited by in Crossref: 67] [Cited by in F6Publishing: 63] [Article Influence: 11.2] [Reference Citation Analysis]
82 Ghisa M, Della Coletta M, Barbuscio I, Marabotto E, Barberio B, Frazzoni M, De Bortoli N, Zentilin P, Tolone S, Ottonello A, Lorenzon G, Savarino V, Savarino E. Updates in the field of non-esophageal gastroesophageal reflux disorder. Expert Rev Gastroenterol Hepatol 2019;13:827-38. [PMID: 31322443 DOI: 10.1080/17474124.2019.1645593] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
83 Jones EL, Perring S, Khattab A, Allenby-smith O. The effects of proton pump inhibitors on autonomic tone in patients with erosive and non-erosive esophagitis. Neurogastroenterol Motil 2016;28:659-64. [DOI: 10.1111/nmo.12761] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
84 Walker R, Wiggins T, Blencowe NS, Findlay JM, Wilson M, Currie AC, Hornby S, Markar SR, Rahman S, Lloyd M, Hollyman M, Jaunoo S; ARROW Study Group. A multicenter prospective audit to investigate the current management of patients undergoing anti-reflux surgery in the UK: Audit & Review of Anti-Reflux Operations & Workup. Dis Esophagus 2021;34:doaa129. [PMID: 33458741 DOI: 10.1093/dote/doaa129] [Reference Citation Analysis]
85 Ogisu K, Masuda A, Fujita T, Yamazaki Y, Kobayashi M, Terao S, Sanuki T, Okada A, Adachi M, Arisaka Y, Miyazaki H, Yoshinaka H, Kutsumi H, Umegaki E, Kodama Y. Influence of sex on the association between body mass index and frequency of upper gastrointestinal symptoms. JGH Open 2020;4:937-44. [PMID: 33102767 DOI: 10.1002/jgh3.12368] [Reference Citation Analysis]
86 Labenz J. [Conservative Therapy of Reflux Disease and its Limits]. Zentralbl Chir 2021;146:176-87. [PMID: 33598907 DOI: 10.1055/a-1309-2368] [Reference Citation Analysis]
87 Wilkinson J, Abd-Elaziz K, den Daas I, Wemer J, van Haastert M, Hodgkinson V, Foster M, Coyle C. Two placebo-controlled crossover studies in healthy subjects to evaluate gastric acid neutralization by an alginate-antacid formulation (Gaviscon Double Action). Drug Dev Ind Pharm 2019;45:430-8. [PMID: 30470147 DOI: 10.1080/03639045.2018.1546314] [Reference Citation Analysis]
88 Chen J, Guo B, Bin C, Zhang C, Zhan Y. Assessment of the Multiple Rapid Swallows Test for Gauging Esophageal Reflux Burden in Patients with Refractory Gastroesophageal Reflux Disease. Med Sci Monit 2021;27:e928554. [PMID: 33602889 DOI: 10.12659/MSM.928554] [Reference Citation Analysis]
89 Kim JJ, Kim N, Choi YJ, Kim JS, Jung HC. Increased TRPV1 and PAR2 mRNA expression levels are associated only with the esophageal reflux symptoms, but not with the extraesophageal reflux symptoms. Medicine (Baltimore) 2016;95:e4387. [PMID: 27512850 DOI: 10.1097/MD.0000000000004387] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
90 Rawla P, Sunkara T, Ofosu A, Gaduputi V. Potassium-competitive acid blockers - are they the next generation of proton pump inhibitors? World J Gastrointest Pharmacol Ther 2018; 9(7): 63-68 [PMID: 30595950 DOI: 10.4292/wjgpt.v9.i7.63] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
91 Pugliese D, Mauro A, Consonni D, Bravi I, Tenca A, Elvevi A, Conte D, Penagini R. pH Impedance vs. traditional pH monitoring in clinical practice: an outcome study. J Gastroenterol 2016;51:130-7. [DOI: 10.1007/s00535-015-1090-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
92 Offman J, Pesola F, Sasieni P. Trends and projections in adenocarcinoma and squamous cell carcinoma of the oesophagus in England from 1971 to 2037. Br J Cancer 2018;118:1391-8. [PMID: 29563637 DOI: 10.1038/s41416-018-0047-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
93 Böhmer AC, Schumacher J. Insights into the genetics of gastroesophageal reflux disease (GERD) and GERD-related disorders. Neurogastroenterol Motil 2017;29. [PMID: 28132438 DOI: 10.1111/nmo.13017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
94 Kim M, Dam A, Green J. Common GI Drug Interactions in the Elderly. Curr Treat Options Gastroenterol 2014;12:292-309. [PMID: 25031070 DOI: 10.1007/s11938-014-0024-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
95 Mion F, Dargent J. Gastro-oesophageal reflux disease and obesity: pathogenesis and response to treatment. Best Pract Res Clin Gastroenterol. 2014;28:611-622. [PMID: 25194179 DOI: 10.1016/j.bpg.2014.07.012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
96 D'Alessandro A, Zito FP, Pesce M, Andreozzi P, Efficie E, Cargiolli M, Maione F, De Palma GD, Cuomo R, Sarnelli G. Specific dyspeptic symptoms are associated with poor response to therapy in patients with gastroesophageal reflux disease. United European Gastroenterol J. 2017;5:54-59. [PMID: 28405322 DOI: 10.1177/2050640616650061] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
97 Carlson DA, Hinchcliff M, Pandolfino JE. Advances in the evaluation and management of esophageal disease of systemic sclerosis. Curr Rheumatol Rep. 2015;17:475. [PMID: 25475597 DOI: 10.1007/s11926-014-0475-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
98 Hungin APS, Molloy-Bland M, Scarpignato C. Revisiting Montreal: New Insights into Symptoms and Their Causes, and Implications for the Future of GERD. Am J Gastroenterol 2019;114:414-21. [PMID: 30323266 DOI: 10.1038/s41395-018-0287-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
99 Ashrafi D, Osland E, Memon MA. Bariatric surgery and gastroesophageal reflux disease. Ann Transl Med 2020;8:S11. [PMID: 32309415 DOI: 10.21037/atm.2019.09.15] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
100 Niu CY, Zhou YS, Wu FX. Individualized medicine of gastroesophageal reflux disease. Shijie Huaren Xiaohua Zazhi 2018; 26(35): 2046-2056 [DOI: 10.11569/wcjd.v26.i35.2046] [Reference Citation Analysis]
101 Hait EJ, McDonald DR. Impact of Gastroesophageal Reflux Disease on Mucosal Immunity and Atopic Disorders. Clin Rev Allergy Immunol 2019;57:213-25. [PMID: 30206783 DOI: 10.1007/s12016-018-8701-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
102 Lim KG, Morgenthaler TI, Katzka DA. Sleep and Nocturnal Gastroesophageal Reflux: An Update. Chest 2018;154:963-71. [PMID: 29859888 DOI: 10.1016/j.chest.2018.05.030] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
103 Lee SP, Sung I, Kim JH, Lee S, Park HS, Shim CS. The Clinical Features and Predisposing Factors of Asymptomatic Erosive Esophagitis. Dig Dis Sci 2016;61:3522-9. [DOI: 10.1007/s10620-016-4341-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
104 Alexandre L, Long E, Beales IL. Pathophysiological mechanisms linking obesity and esophageal adenocarcinoma. World J Gastrointest Pathophysiol 2014; 5(4): 534-549 [PMID: 25400997 DOI: 10.4291/wjgp.v5.i4.534] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
105 Kim SY, Kim HJ, Lim H, Lim MS, Kim M, Choi HG. Increased risk of appendectomy in patients with gastroesophageal reflux disease: A nested case-control study using a national sample cohort. Medicine (Baltimore) 2018;97:e13700. [PMID: 30593140 DOI: 10.1097/MD.0000000000013700] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
106 Yadlapati R, Pandolfino JE, Alexeeva O, Gregory DL, Craven MR, Liebovitz D, Lichten A, Seger E, Workman M, St Peter N, Craft J, Doerfler B, Keswani RN. The Reflux Improvement and Monitoring (TRIM) Program Is Associated With Symptom Improvement and Weight Reduction for Patients With Obesity and Gastroesophageal Reflux Disease. Am J Gastroenterol 2018;113:23-30. [PMID: 29016559 DOI: 10.1038/ajg.2017.262] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
107 Håkansson B, Montgomery M, Cadiere GB, Rajan A, Bruley des Varannes S, Lerhun M, Coron E, Tack J, Bischops R, Thorell A, Arnelo U, Lundell L. Randomised clinical trial: transoral incisionless fundoplication vs. sham intervention to control chronic GERD. Aliment Pharmacol Ther 2015;42:1261-70. [PMID: 26463242 DOI: 10.1111/apt.13427] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 7.4] [Reference Citation Analysis]
108 Mössner J. The Indications, Applications, and Risks of Proton Pump Inhibitors. Dtsch Arztebl Int 2016;113:477-83. [PMID: 27476707 DOI: 10.3238/arztebl.2016.0477] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
109 Wang YF, Yang CQ, Chen YX, Cao AP, Yu XF, Yu Y, Zhang ZY, Shen XZ, Liu F, Zhong L, Wang YX, Liu ZJ, Shi YH, Zhong J, Li JN, Lan Y, Lenham RK, Woodcock AD, Dettmar PW, Fang JY. Validation in China of a non-invasive salivary pepsin biomarker containing two unique human pepsin monoclonal antibodies to diagnose gastroesophageal reflux disease. J Dig Dis 2019;20:278-87. [PMID: 31090180 DOI: 10.1111/1751-2980.12783] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
110 Mikami H, Ishimura N, Okada M, Izumi D, Okimoto E, Ishihara S, Kinoshita Y. Acotiamide Has No Effects on Esophageal Motor Activity or Esophagogastric Junction Compliance. J Neurogastroenterol Motil 2018;24:241-7. [PMID: 29605979 DOI: 10.5056/jnm16111] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
111 Kim YS, Kim N, Kim GH. Sex and Gender Differences in Gastroesophageal Reflux Disease. J Neurogastroenterol Motil. 2016;22:575-588. [PMID: 27703114 DOI: 10.5056/jnm16138] [Cited by in Crossref: 57] [Cited by in F6Publishing: 46] [Article Influence: 9.5] [Reference Citation Analysis]